Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial
Outrage has erupted among health experts over news that the Centers for Disease Control and Prevention is still eager to fund a widely condemned vaccine…
Ars Technica reports: Outrage has erupted among health experts over news that the Centers for Disease Control and Prevention is still eager to fund a widely condemned vaccine trial that would expose newborns in Guinea-Bissau to hepatitis B, putting them at high risk of a lifelong infection, which can lead to liver cirrhosis, liver cancer, and premature death.
The trial was suspended in January after its unethical design came to light and drew international outcry.
This health story centres on the United States. Names and organisations mentioned in the coverage include CDC, Centers for Disease Control and Prevention.
Why it matters
Health stories are worth following because they can shape treatment options, guidance and how services are delivered. Readers should rely on medical professionals for personal advice.
Key details
- Location
- United States · Americas
- Reported by
- Ars Technica
- First reported
- Key names
- CDC, Centers for Disease Control, Prevention, Guinea-Bissau
- Section
- Health
- Figure cited
- Although the trial is still halted, staff of the CDC director's office told the agency's budget office in late September to set aside $1.6… (Ars Technica)
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at Ars TechnicaSpotted an error? Request a correction · How this summary was produced
Related Stories
Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau
It is a central part of the vaccine vision for Robert F Kennedy Jr, the secretary of the US Department of Health and Human Services (HHS) and a…
How to define a measles death
Historically, the CDC relied on state health departments' determination of measles deaths.
Generative AI Still Needs Artists’ Judgment, Says Netflix’s Eyeline GenFX Chief James Rustad at Busan
Generative AI can widen the options for a visual effects shot, but artists still decide which of them serve the story, according to James Rustad…
Netflix’s ‘The Blue Road’ Director Han Jun-hee on Why Playing It Safe Is the Real Risk
When Han Jun-hee binge-watched “House of Cards,” the series struck him as a game changer.
'What terminal cancer has taught me about life'
A Gloucestershire man with terminal cancer shares the life lessons he wishes he'd learned sooner.
How the trial of murdered Australian brothers and US friend unfolded
The mother of two Australian surfers murdered in Mexico two years ago with their American friend said "accountability matters".
What happens when you don't know your family medical history?
People who have been adopted or in care sometimes struggle to access family medical history which would be crucial to their own health.
Nord Stream trial: How German police followed the evidence - to Ukraine
After four years, a Ukrainian man is set to stand trial in Hamburg accused of sabotaging the Nord Stream pipelines.